Neogenomics logo

Neogenomics Share Price (NASDAQ: NEO)

$6.59

0.41

(6.63%)

Last updated on

Check the interactive Neogenomics Stock chart to analyse performance

Neogenomics stock performance

as on August 23, 2025 at 1:29 AM IST

  • Today's Low:$6.28
    Today's High:$6.61

    Day's Volatility :4.99%

  • 52 Weeks Low:$4.72
    52 Weeks High:$19.12

    52 Weeks Volatility :75.31%

Neogenomics Stock Returns

PeriodNeogenomics, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-12.2%
6.0%
0.0%
6 Months
-41.05%
-7.2%
0.0%
1 Year
-59.8%
-11.1%
0.0%
3 Years
-38.46%
5.5%
-10.0%

Neogenomics, Inc. Key Stats

Check Neogenomics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$6.18
Open
$6.28
Today's High
$6.61
Today's Low
$6.28
Market Capitalization
$798.3M
Today's Volume
$1.8M
52 Week High
$19.115
52 Week Low
$4.72
Revenue TTM
$689.2M
EBITDA
$-7.8M
Earnings Per Share (EPS)
$-0.82
Profit Margin
-15.1%
Quarterly Earnings Growth YOY
1.31%
Return On Equity TTM
-11.76%

Stock Returns calculator for Neogenomics Stock including INR - Dollar returns

The Neogenomics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Neogenomics investment value today

Current value as on today

₹44,548

Returns

₹55,452

(-55.45%)

Returns from Neogenomics Stock

₹59,768 (-59.77%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Neogenomics Stock

86.67%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Investment in Neogenomics Shares from India has grown by 86.67% over the past 30 days, indicating increased transactional activity.

71%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Search interest for Neogenomics Stock from India on INDmoney has increased by 71% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Neogenomics, Inc.

  • Name

    Holdings %

  • BlackRock Inc

    15.38%

  • Vanguard Group Inc

    10.94%

  • Greenhouse Funds LLLP

    5.75%

  • First Light Asset Management, LLC

    5.30%

  • Millennium Management LLC

    5.20%

  • State Street Corp

    3.94%

Analyst Recommendation on Neogenomics Stock

Rating
Trend

Buy

    76%Buy

    23%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Neogenomics(by analysts ranked 0 to 5 stars)

Neogenomics Share Price Target

What analysts predicted

Upside of 30.67%

Target:

$8.61

Current:

$6.59

Neogenomics share price target is $8.61, a slight Upside of 30.67% compared to current price of $6.59 as per analysts' prediction.

Neogenomics Stock Insights

  • Price Movement

    In the last 6 months, NEO stock has moved down by -39.5%
  • Price Movement

    In the last 3 months, NEO stock has moved down by -16.0%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 168.03M → 181.33M (in $), with an average increase of 7.3% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -15.32M → -45.09M (in $), with an average decrease of 71.6% per quarter
  • NEO vs IDXX (1 yr)

    In the last 1 year, Idexx Laboratories, Inc. has given 32.2% return, outperforming this stock by 92.7%
  • NEO vs IDXX (3 yr)

    In the last 3 years, Idexx Laboratories, Inc. has given 73.9% return, outperforming this stock by 117.1%
  • Price to Sales

    ForNEO every $1 of sales, investors are willing to pay $1.2, whereas for Idexx Laboratories, Inc., the investors are paying $13.0 for every $1 of sales.

Neogenomics, Inc. Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$660.6M
↑ 11.65%
Net Income
$-78.7M
↓ 10.51%
Net Profit Margin
-11.92%
↑ 2.95%

Neogenomics Technicals Summary

Sell

Neutral

Buy

Neogenomics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Neogenomics, Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Neogenomics, Inc. logo
4.69%
-41.05%
-59.8%
-38.46%
-83.06%
Agilent Technologies Inc. logo
1.75%
-10.09%
-13.42%
-6.34%
22.45%
Idexx Laboratories, Inc. logo
13.93%
39.2%
33.33%
84.45%
67.19%
Thermo Fisher Scientific, Inc. logo
3.14%
-6.6%
-17.4%
-11.27%
17.51%
Danaher Corp. logo
4.3%
0.25%
-21.04%
-24.49%
1.67%
Iqvia Holdings Inc. logo
-3.36%
-1.87%
-22.9%
-13.0%
20.56%

Neogenomics Dividend announcements

  • Neogenomics Earnings

    Neogenomics’s price-to-earnings ratio stands at None

About Neogenomics, Inc.

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
Organization
Neogenomics
Employees
2200
CEO
Mr. Anthony P. Zook
Industry
Health Services

Key Management of Neogenomics, Inc.

NameTitle
Mr. Anthony P. Zook
CEO & Director
Mr. Warren Stone
President & COO
Mr. Jeffrey S. Sherman M.B.A.
Chief Financial Officer
Ms. Alicia C. Olivo
Executive VP of Business Development, General Counsel & Corporate Secretary
Mr. Gregory D. Aunan
Senior VP & Chief Accounting Officer
Ms. Kendra Sweeney
Vice President of Investor Relations & Communications
Mr. Hutan Hashemi J.D.
Chief Compliance Officer
Mr. Gary Passman
Chief People & Culture Officer
Mr. Kareem M. Saad
Head of Strategy, Business Development & Transformation
Dr. Andrew A. Lukowiak Ph.D.
Chief Innovation Officer

Important FAQs about investing in NEO Stock from India :

What is Neogenomics share price today?

Neogenomics share price today is $6.59 as on at the close of the market. Neogenomics share today touched a day high of $6.61 and a low of $6.28.

What is the 52 week high and 52 week low for Neogenomics share?

Neogenomics share touched a 52 week high of $19.12 and a 52 week low of $4.72. Neogenomics stock price today i.e. is closed at $6.59, lower by 65.52% versus the 52 week high.

How to invest in Neogenomics Stock (NEO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Neogenomics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neogenomics Shares that will get you 0.2276 shares as per Neogenomics share price of $6.59 per share as on August 23, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Neogenomics Stock (NEO) from India?

Indian investors can start investing in Neogenomics (NEO) shares with as little as ₹87.521 or $1 (as of August 25, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Neogenomics stock (as per the Rupee-Dollar exchange rate as on August 25, 2025). Based on Neogenomics share’s latest price of $6.59 as on August 23, 2025 at 1:29 AM IST, you will get 1.5175 shares of Neogenomics. Learn more about fractional shares .

What are the returns that Neogenomics has given to Indian investors in the last 5 years?

Neogenomics stock has given -83.06% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?